In fiscal year 2019 , the Japanese pharmaceutical company Takeda Pharmaceutical Co. , Ltd. recorded net profits of approximately 44.29 billion Japanese yen , down from around 135.08 billion yen in the previous fiscal year . The company focuses mainly on the therapeutic areas oncology , gastroenterology and neuroscience .
